Showing results (111-120 of 120) with videos related to
Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
ACS Medicinal Chemistry Letters|April 20, 2018
Imidazo[2,1-b]benzothiazol Derivatives as Potential Allosteric Inhibitors of the Glucocorticoid ReceptorMichael S Christodoulou, Federico Dapiaggi, Francesca Ghiringhelli, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 31, 2023
Gene expression profiling in white blood cells reveals new insights into the molecular mechanisms of thalidomide in children with inflammatory bowel diseaseLetizia Pugnetti, Debora Curci, Carlotta Bidoli, et al.Blood|September 5, 2008
Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemiaJun J Yang, Deepa Bhojwani, Wenjian Yang, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 14, 2025
Unraveling the cellular mechanisms of thiopurine-induced pancreatitis in pediatric inflammatory bowel disease: Insights from induced pluripotent stem cell modelsPaola Rispoli, Elena Genova, Fengming Yue, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 3, 2022
DNA methylation of the TPMT gene and azathioprine pharmacokinetics in children with very early onset inflammatory bowel diseaseDavide Selvestrel, Gabriele Stocco, Marina Aloi, et al.Human Molecular Genetics|August 1, 2012
PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicityGabriele Stocco, Wenjian Yang, Kristine R Crews, et al.Journal of Molecular Medicine (Berlin, Germany)|April 28, 2020
Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitisGiorgia Colombo, Nausicaa Clemente, Andrea Zito, et al.Inflammatory Bowel Diseases|August 18, 2017
Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease CohortMatteo Bramuzzo, Gabriele Stocco, Marcella Montico, et al.Nature Genetics|May 5, 2015
NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cellsSteven W Paugh, Erik J Bonten, Daniel Savic, et al.Nature Communications|December 21, 2017
Type I interferon-mediated autoinflammation due to DNase II deficiencyMathieu P Rodero, Alessandra Tesser, Eva Bartok, et al.Pageof 12